Being a premium partner for pharmaceutical companies by contributing to safety and productivity of pharmaceutical manufacture
L-HPC was independently developed by Shin-Etsu Chemical as a disintegrant for tablets
This marks a significant milestone in Morepen’s strategic entry into one of the world’s largest pharmaceutical markets
The new combination therapy offers a dual mechanism of action for superior intraocular pressure control
EC decision marks the fourth approval for CAPVAXIVE for pneumococcal vaccination in adults
Prior to joining Neuland, Deshmukh held several key positions at Cipla
The inspection, conducted from March 17 to March 21, 2025, concluded with one observation in Form 483
First-of-its-kind active cosmetic ingredient directly activates the oxytocin receptor, mimicking the dermatological effects of being in love
This program aims to develop a fully human monoclonal antibody against a novel immune checkpoint protein that enables T cell activation
Subscribe To Our Newsletter & Stay Updated
